GREATWALL vs Greenyn Biotechnology: monthly revenue

Monthly revenue and year-on-year change for GREATWALL (1210) and Greenyn Biotechnology (6846) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GREATWALL ━ Greenyn Biotechnology

0%+32%-56%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGREATWALLYoYGreenyn BiotechnologyYoY
Oct 2026NT$9.66 billion+14.6%NT$62.2 million-31.1%
Sep 2026NT$9.88 billion+13.2%NT$77.5 million+31.0%
Aug 2026NT$9.7 billion+13.4%NT$63.8 million-11.3%
Jul 2026NT$9.64 billion+21.5%NT$62.2 million-16.5%
Jun 2026NT$8.95 billion+12.2%NT$66.8 million+5.7%
May 2026NT$9.07 billion+10.2%NT$64.7 million-20.4%
Apr 2026NT$9.1 billion+4.3%NT$64.3 million-0.1%
Mar 2026NT$9.21 billion+5.0%NT$99.4 million+20.5%
Feb 2026NT$7.63 billion-5.7%NT$42.8 million-56.2%
Jan 2026NT$9.73 billion+12.0%NT$55.9 million+6.3%
Dec 2025NT$9.59 billion+4.6%NT$104.8 million+12.2%
Nov 2025NT$8.86 billion-1.2%NT$73.2 million-13.5%
Oct 2025NT$8.43 billion-2.0%NT$90.3 million+32.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16